Evidence map›Paper›PMID 37396107›Full record

ReviewEcancermedicalscience2023

Radiation therapy after radical surgery in prostate cancer.

Roberto Paz-Manrique, Gerard Morton, Fernando Quiroa Vera, Santiago Paz-Manrique, Andrés Espinoza-Briones, Carlos Morante Deza

Abstract readReview
In one paragraph

Review in Ecancermedicalscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Cancers · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Roberto Paz-ManriqueOncosalud - AUNA, Lima 15036, Peru.
Gerard MortonDepartment of Radiation Oncology, Sunnybrook Odette Cancer Center, Toronto, ON M4N 3M5, Canada.
Fernando Quiroa VeraInstituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.
Santiago Paz-ManriqueUniversidad Católica de Santa Maria, Arequipa 04013, Peru.
Andrés Espinoza-BrionesDepartment of General, Visceral and Vascular Surgery, University Hospital Jena, Jena 07743, Germany.
Carlos Morante DezaInstituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiation therapy plays a key role in the treatment of prostate cancer on its own. For higher risk diseases, the risk of recurrence following single modality therapy increases and a combination of treatment modalities may be necessary to achieve optimal results. We review clinical outcomes of adjuvant and salvage radiotherapy following radical prostatectomy, including disease-free survival, cancer-specific survival and overall survival. We also discuss when best to intervene with post-prostatectomy radiotherapy.

Indexed as

adjuvantcancerprostateradiationradicalsalvagesurgerytherapy

Identifiers

PMID37396107
PMCPMC10310328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.